Skip to main content
. 2017 Nov 16;2017(11):CD004863. doi: 10.1002/14651858.CD004863.pub5

Analysis 1.46.

Analysis 1.46

Comparison 1 Erythropoietin versus placebo or no treatment, Outcome 46 Survival without major neurological or neurodevelopmental disorders at 2 years of age.